These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 15490419)

  • 1. Plasma levels of plasminogen activator inhibitor type 1, factor VIII, prothrombin activation fragment 1+2, anticardiolipin, and antiprothrombin antibodies are risk factors for thrombosis in hemodialysis patients.
    Molino D; De Santo NG; Marotta R; Anastasio P; Mosavat M; De Lucia D
    Semin Nephrol; 2004 Sep; 24(5):495-501. PubMed ID: 15490419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In uremia, plasma levels of anti-protein C and anti-protein S antibodies are associated with thrombosis.
    Molino D; De Lucia D; Marotta R; Perna A; Lombardi C; Cirillo M; De Santo NG
    Kidney Int; 2005 Sep; 68(3):1223-9. PubMed ID: 16105054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticardiolipin antibodies and lupus anticoagulant in patients treated with different methods of renal replacement therapy in comparison to patients with systemic lupus erythematosus.
    Sitter T; Spannagl M; Schiffl H
    Ann Hematol; 1992 Aug; 65(2):79-82. PubMed ID: 1511061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticardiolipin, anti-beta(2)-glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis.
    Swadzba J; De Clerck LS; Stevens WJ; Bridts CH; van Cotthem KA; Musial J; Jankowski M; Szczeklik A
    J Rheumatol; 1997 Sep; 24(9):1710-5. PubMed ID: 9292792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study on associations between antiprothrombin antibodies, antiplasminogen antibodies and thrombosis.
    Simmelink MJ; De Groot PG; Derksen RH
    J Thromb Haemost; 2003 Apr; 1(4):735-9. PubMed ID: 12871409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies.
    Horbach DA; van Oort E; Donders RC; Derksen RH; de Groot PG
    Thromb Haemost; 1996 Dec; 76(6):916-24. PubMed ID: 8972011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies to human prothrombin and clinical manifestations in 207 patients with systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Khamashta MA; Amengual O; Hughes GR
    J Rheumatol; 1998 Jun; 25(6):1104-8. PubMed ID: 9632071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrinogen, coagulation factor VII, tissue plasminogen activator, plasminogen activator inhibitor-1, and lipid as cardiovascular risk factors in chronic hemodialysis and continuous ambulatory peritoneal dialysis patients.
    Tomura S; Nakamura Y; Doi M; Ando R; Ida T; Chida Y; Ootsuka S; Shinoda T; Yanagi H; Tsuchiya S; Marumo F
    Am J Kidney Dis; 1996 Jun; 27(6):848-54. PubMed ID: 8651250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgM anticardiolipin antibodies are associated with stenosis of vascular access in hemodialysis patients but do not predict thrombosis.
    Adler S; Szczech L; Qureshi A; Bollu R; Thomas-John R
    Clin Nephrol; 2001 Dec; 56(6):428-34. PubMed ID: 11770794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The factor V Leiden mutation, high factor VIII, and high plasminogen activator inhibitor activity: etiologies for sporadic miscarriage.
    Glueck CJ; Pranikoff J; Aregawi D; Haque M; Zhu B; Tracy T; Wang P
    Metabolism; 2005 Oct; 54(10):1345-9. PubMed ID: 16154434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antiphospholipid antibodies and thrombosis: the putative mechanisms of hypercoagulable state in patients with anticardiolipin antibody].
    Ieko M
    Rinsho Byori; 2000 Apr; 48(4):293-300. PubMed ID: 10810873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombotic events in systemic lupus erythematosus. Its association with acquired and inherited thrombophilic defects.
    Vayá A; Santaolaria M; Micó L; Calvo J; Oropesa R; Villa P; Todoli J; Simó M; Corella D; Ricart JM
    Clin Hemorheol Microcirc; 2008; 40(2):79-87. PubMed ID: 19029633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiphospholipid antibody tests: spreading the net.
    Bertolaccini ML; Gomez S; Pareja JF; Theodoridou A; Sanna G; Hughes GR; Khamashta MA
    Ann Rheum Dis; 2005 Nov; 64(11):1639-43. PubMed ID: 15817655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular vascular thrombotic events: central retinal vein and central retinal artery occlusions.
    Glueck CJ; Ping Wang ; Hutchins R; Petersen MR; Golnik K
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):286-94. PubMed ID: 18160589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
    Viveros ME; Cabiedes J; Reyes E; Cabral AR
    Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiphospholipid Syndrome with Antiβ2glicoprotein-1 Antibodies as the Cause of Recurrent Tibial Vein Thrombosis in SAPHO syndrome.
    Przepiera-Będzak H; Brzosko M
    Acta Dermatovenerol Croat; 2016 Dec; 24(4):305-306. PubMed ID: 28128085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
    Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
    Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detecting anti-prothrombin antibodies in young women with acute ischemic stroke.
    Cojocaru IM; Cojocaru M; Tănăsescu R; Burcin C; Mitu AC; Iliescu I; Dumitrescu L; Pavel I; Silosi I
    Rom J Intern Med; 2008; 46(4):337-41. PubMed ID: 19480300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome.
    Van Geet C; Proesmans W; Arnout J; Vermylen J; Declerck PJ
    Kidney Int; 1998 Oct; 54(4):1324-30. PubMed ID: 9767551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.